In this Session, Val Hoffman, psychiatric epidemiologist and founder of Pogo Research, shared practical frameworks for generating evidence within a startup’s limits. She covered how to collect data from day one, design studies that satisfy several stakeholders, and turn research into ROI models that buyers trust.
Speakers
Val Hoffman
Speaker · Psychiatric Epidemiologist, Founder & CEO of Pogo Research; former Chief Research Officer at Meru Health and VP of Intervention Science at Woebot Health
Val Hoffman is a psychiatric epidemiologist who has spent nearly 25 years at the intersection of mental health research and digital innovation. Her career spans academic research, industry leadership, and digital health product development, including roles as Chief Research Officer at Meru Health and VP of Intervention Science at Woebot Health.
What you will learn:
What buyers prioritise, and the three pillars of minimum evidence.
Which evidence you need at each stage of the company.
How to build ROI tracking into your product from day one.
How to design pragmatic studies that satisfy several stakeholders.
How to link clinical measures to financial impact, and where ROI meets pricing.
Read the full recap and open the slides
Full Session notes, slides and resources are for Hemingway Pro members.
